$NRED is waking up fast. AI, robotics and a full strategy reset put this one firmly on my radar $MSFT $AMZN $META $GOOGL $AMD $NFLX $AVGO

$NRED.CN robotics angle may be one of the most overlooked parts of the new strategy $NRED The company says it wants to develop robotic and autonomous technologies for mining and exploration, alongside MetalCore AI Think underground inspection, mapping, remote operations and safer work in hazardous environments. AI + robotics + mining is becoming the real NRED story

$NRED up +15.38% today as traders react to the company’s strategic shift toward MetalCore AI, mining robotics and automation. At just ~$2.47M market cap, this is a very small name with a much bigger mining-tech story developing. Momentum is here. Now execution matters

🚨BREAKING: $NRED is moving into mining robotics and autonomous systems The company’s new strategy now centers on MetalCore AI, robotics and automation designed to make mining and exploration safer, smarter and more efficient New CEO Valentin Saitarli brings 10+ years in AI and computer vision

$NRED is making a major strategic shift. Instead of focusing mainly on one mining project, the company is redirecting resources toward MetalCore, AI-driven mineral exploration, and mining robotics. That robotics angle could matter more than people realize. Mining is moving toward autonomous drilling, robotic inspection, computer vision, LiDAR mapping, remote equipment and AI systems that can work in places that are dangerous, expensive or difficult for people to access. If NRED can combine MetalCore’s geological intelligence with robotics and automation, the bigger opportunity is not just finding mineral targets. It’s building technology that could help mining companies decide where to explore, how to inspect sites, and eventually how to operate more efficiently with less human exposure to hazardous environments. That is a much broader story than a single copper-gold property. AI + mining data + robotics is the new direction.

$NRED is officially pivoting toward AI. The company is dropping the Wilmac Copper-Gold options to focus on MetalCore, its AI-driven mining platform, plus related robotics and automation. CTO Valentin Saitarli is now CEO, putting an AI/computer vision operator at the center of the new strategy $AMD $NVDA

Put $30K into $RYET and caught roughly a 14% move over the past 5 days That’s about $4,200 in gains on paper. The Malaysia healthcare catalyst, Cogni AI story and improving momentum all helped keep this one on my radar $GOOGL $PLTR $NFLX $AVGO

BREAKING: $RYET just added a completely new business lane in Malaysia. The company announced an agreement with BioNexus Gene Lab that brings Cogni AI into healthcare, moving the technology beyond education and enterprise use cases

The bigger picture behind the latest $RYET news is much larger than one Malaysia agreement AI in healthcare is becoming a global industry. Current market estimates put the sector at roughly $56B in 2026, with forecasts reaching around $1 TRILLION by 2034. That is the market backdrop for RYET latest move. Ruanyun announced a definitive agreement involving Cogni AI and BioNexus Gene Lab in Malaysia, giving its AI technology a path into healthcare rather than keeping it limited to education and enterprise applications. The structure is interesting too: an exclusive license framework of up to 20 years, 10% royalty economics on qualifying technology receipts, and 560K BGLC shares at closing. For me, this is what makes the news important. RYET is not suddenly becoming a healthcare giant. It is testing whether Cogni AI can be licensed into a completely different industry and international market while that industry itself is experiencing massive AI adoption. Education was the starting point. Enterprise AI expanded the story. Now healthcare adds another potential use case. If Cogni AI can continue moving across industries and markets, that becomes a much more interesting business model than relying on one product or one sector. Malaysia may be only the first healthcare test, but it puts RYET directly in front of one of the fastest-growing global technology trends.

BREAKING: $RYET just added a completely new business lane in Malaysia. The company announced an agreement with BioNexus Gene Lab that brings Cogni AI into healthcare, moving the technology beyond education and enterprise use cases

$RYET just opened a new growth lane The company is moving into Malaysian healthcare through an exclusive agreement, adding another vertical to its international expansion story. AI. Education. Smart Campus. Now healthcare. Malaysia is becoming a much bigger part of the $RYET story

BREAKING: $RYET is expanding into Malaysian healthcare 🇲🇾 Ruanyun/Formind announced an exclusive Cogni AI licensing agreement with Nasdaq-listed BioNexus Gene Lab, opening a completely new healthcare vertical for the company. Key terms: • Exclusive Cogni AI license for up to 20 years • 10% royalty on qualifying technology receipts • 560,000 BGLC shares to RYET at closing • Focus on AI-powered healthcare applications in Malaysia BioNexus operates in genomic screening and precision healthcare, giving Cogni AI a potential path into real healthcare workflows This comes as $RYET is already expanding beyond its original education business into AI platforms, Smart Campus services and international markets. Education. Enterprise AI. Now healthcare Malaysia is becoming a much bigger part of the Formind expansion story.

AI + education is becoming a bigger global theme. $RYET is expanding beyond China with smart campus tools, AI platforms and international education projects, while preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M

Catch the market catalysts that matter Daily Market Memo tracks breaking company news, unusual activity and fresh market developments so traders can quickly see what deserves deeper research Free market research: dailymarketmemo.com/discord

This is the $RYET update I wanted to highlight again Preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M, versus only about $0.37M in H1 FY2026 And that six-month figure already exceeds the company’s $7.48M FY2026 full-year revenue That is a major change in operating scale Preliminary and unaudited, but the revenue growth is now the main story to watch xitter.cf/TradePulse2/status/210…

The biggest number in the $RYET story today is $9.3M-$9.5M That is expected preliminary H1 FY2027 revenue, compared with only about $0.37M in H1 FY2026 The business is operating at a completely different scale now $OPEN $QQQ

$RYET H1 FY2027 revenue is expected at $9.3M-$9.5M That’s not just growth - it’s a major scale shift compared with ~$0.37M in H1 FY2026 If these preliminary numbers hold, the financial story looks very different now